{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:06:26Z","timestamp":1791378386016,"version":"4.3.2"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In recent years, there has been growing interest in cardiac toxicity following radiation therapy (RT) for esophageal cancer; however, detailed incidence and risk factors in Japanese patients remain unclear. The purpose of this study was to clarify the incidence, timing, risk factors, and dose-volume relationships of multiple cardiac toxicities, including pericardial effusion, heart failure, arrhythmia, cardiac valve disease and acute coronary syndrome. We retrospectively analyzed patients of thoracic esophageal cancer without distant metastasis who were treated with curative RT at our hospital between 2007 and 2020. Cardiac toxicity events were graded according to common terminology criteria for adverse events v5.0. Association between cardiac dose-volume parameters and grade 2 or higher toxicity was analyzed using logistic regression analysis. The analysis included 250 patients, with a median follow-up period of 21\u00a0months. The 2-year cumulative incidence of grade 2 or higher pericardial effusion, heart failure, arrhythmia, and acute coronary syndrome were 36.6%, 0.4%, 1.4%, and 1.3%, respectively. Logistic regression analysis identified the volume of the whole heart receiving 30Gy as a significant risk factor for grade 2 pericardial effusion (OR, 1.03; 95% confidence interval [CI], 1.01\u20131.04; P\u2009&amp;lt;\u20090.01) and grade 2 arrhythmia (OR, 1.10; 95%CI, 1.02\u20131.18; P\u2009=\u20090.01). We reported detailed profile of cardiac toxicity in Japanese patients who received curative RT for esophageal cancer. Reducing cardiac radiation dose may reduce the risk of pericardial effusion and arrhythmia.<\/jats:p>","DOI":"10.1093\/jrr\/rraf056","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T11:49:32Z","timestamp":1755085772000},"page":"645-651","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of cardiac toxicity after definitive radiation therapy for thoracic esophageal cancer in Japanese patients"],"prefix":"10.1093","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3190-626X","authenticated-orcid":false,"given":"Keita","family":"Tsukahara","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6209-9446","authenticated-orcid":false,"given":"Takanori","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Iino","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3803-9336","authenticated-orcid":false,"given":"Tomomi","family":"Aoshika","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ryuno","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genta","family":"Michimata","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu","family":"Igari","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-4546","authenticated-orcid":false,"given":"Yu","family":"Kumazaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-3251","authenticated-orcid":false,"given":"Shin-ei","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5301-3185","authenticated-orcid":false,"given":"Shingo","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, International Medical Center, Saitama Medical University , 1397-1, Yamane, Hidaka, Saitama 350-1298 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"2025112604220260100_ref1","article-title":"NCCN clinical practice guidelines in oncology (NCC guidelines\u00ae). Esophageal and esophagogastric junction cancers. Version 2","author":"National Comprehensive Cancer Network","year":"2025"},{"key":"2025112604220260100_ref2","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","article-title":"Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I Esophageal squamous cell carcinoma","volume":"161","author":"Kato","year":"2021","journal-title":"Gastroenterology"},{"key":"2025112604220260100_ref3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jjco\/hyh107","article-title":"Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)\/Japan Clinical Oncology Group Trial (JCOG9516)","volume":"34","author":"Ishida","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"2025112604220260100_ref4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cas.12622","article-title":"Japan clinical oncology group. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)","volume":"106","author":"Shinoda","year":"2015","journal-title":"Cancer Sci"},{"key":"2025112604220260100_ref5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.rpor.2020.02.005","article-title":"Cardiotoxicity of radiation therapy in esophageal cancer","volume":"25","author":"Vo\u0161mik","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"2025112604220260100_ref6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijrobp.2023.05.025","article-title":"Late toxicity and health-related quality of life following definitive chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis","volume":"117","author":"Pape","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112604220260100_ref7","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2025112604220260100_ref8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12885-019-5421-y","article-title":"The heart's exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study","volume":"19","author":"Hayashi","year":"2019","journal-title":"BMC Cancer"},{"key":"2025112604220260100_ref9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jrr\/rrad040","article-title":"Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancer","volume":"64","author":"Umezawa","year":"2023","journal-title":"J Radiat Res"},{"key":"2025112604220260100_ref10","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"key":"2025112604220260100_ref11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00066-016-0956-1","article-title":"Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer","volume":"192","author":"Ogino","journal-title":"Strahlenther Onkol"},{"key":"2025112604220260100_ref12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijrobp.2013.07.008","article-title":"Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients","volume":"87","author":"Fukada","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112604220260100_ref13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2010.03.046","article-title":"Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients","volume":"80","author":"Shirai","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112604220260100_ref14","first-page":"7389","article-title":"Risk factors for pericardial effusion in patients with stage I esophageal cancer treated with chemoradiotherapy","volume":"34","author":"Tamari","year":"2014","journal-title":"Anticancer Res"},{"key":"2025112604220260100_ref15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13014-015-0482-9","article-title":"Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study","volume":"10","author":"Yamashita","year":"2015","journal-title":"Radiat Oncol"},{"key":"2025112604220260100_ref16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112604220260100_ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2023.08.011","article-title":"Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy","volume":"118","author":"Miller","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112604220260100_ref18","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2025112604220260100_ref19","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.108.790048","article-title":"Cardiovascular disease and risk factors in Asia: a selected review","volume":"118","author":"Ueshima","year":"2008","journal-title":"Circulation"},{"key":"2025112604220260100_ref20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13014-020-01498-3","article-title":"Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer","volume":"15","author":"Pao","year":"2020","journal-title":"Radiat Oncol"},{"key":"2025112604220260100_ref21","doi-asserted-by":"crossref","first-page":"110085","DOI":"10.1016\/j.radonc.2024.110085","article-title":"Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis","volume":"192","author":"Walls","year":"2024","journal-title":"Radiother Oncol"},{"key":"2025112604220260100_ref22","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2022.4202","article-title":"Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer","volume":"8","author":"Kim","year":"2022","journal-title":"JAMA Oncol"},{"key":"2025112604220260100_ref23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025112604220260100_ref24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","article-title":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?","volume":"114","author":"Beukema","year":"2015","journal-title":"Radiother Oncol"},{"key":"2025112604220260100_ref25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2025112604220260100_ref26","article-title":"Clinical characteristics and risk analysis of cardiotoxicity after definitive radiotherapy for thoracic esophageal cancer","author":"Keita","year":"2024","journal-title":"Proceedings of the 37th Annual Meeting of the Japanese Society of Radiation Oncology"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/66\/6\/645\/64356657\/rraf056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/66\/6\/645\/64356657\/rraf056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T09:22:13Z","timestamp":1764148933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/66\/6\/645\/8262623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,23]]},"published-print":{"date-parts":[[2025,11,25]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rraf056","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,23]]}}}